(Q34176438)

31 July 2017

title

Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes (English)

1 reference

31 July 2017

Søren K Rasmussen

1

1 reference

31 July 2017

Lars S Nielsen

2

1 reference

31 July 2017

Christian Müller

3

1 reference

31 July 2017

Thomas Bouquin

4

1 reference

31 July 2017

Henrik Næsted

5

1 reference

31 July 2017

Nina T Mønster

6

1 reference

31 July 2017

Frank Nygaard

7

1 reference

31 July 2017

Dietmar Weilguny

8

1 reference

31 July 2017

Torben P Frandsen

9

1 reference

31 July 2017

Anne B Tolstrup

10

1 reference

31 July 2017

publication date

22 November 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

5 Suppl 8

1 reference

31 July 2017

page(s)

O2

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

copyright license

start time

22 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285016

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285016

Single-batch production of recombinant human polyclonal antibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285016

Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285016

Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285016

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285016

Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1753-6561-5-S8-O2

10.1186/1753-6561-5-S8-O2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference